Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-04

Clinical Trial Update: Monocentric Pilot Study, for a Randomized, Crossover, Blinded Trial: Comparison of the Therapeutic Efficacy of Low Frequency Repeated Transcranial Magnetic Stimulation on Cortical Area 9 Compared to Brodmann Area 46 in the Treatment of Depressive Disorders. [Phase 2]

View source ↗

Summary

Phase 2 randomized, crossover, blinded trial comparing low-frequency rTMS over cortical area 9 vs Brodmann area 46 for resistant depressive disorders; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Patients With Resistant Depressive Disorders | Phase 2 | Status: COMPLETED